Results 111 to 120 of about 29,024 (207)

STATA tip: A quick trick to perform a Roy-Zellner test for poolability in Stata [PDF]

We show how to easily implement a Roy-Zellner test for poolability in STATA and we offer an application to the Grunfeld dataset.poolability, Roy-Zellner test, Grunfeld ...
Andrea Vaona
core  

Editorial: New concepts in revascularization strategies and antithrombotic therapies in patients with non-ST elevated acute coronary syndromes. [PDF]

Front Cardiovasc Med
Mojoli M, Rathod K, Zuin M.
europepmc   +1 more source

Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort. [PDF]

Antibodies (Basel)
Bagnara D, Mazzarello AN, Colombo M, Nano E, Cardente N, Ferrero F, Bertola N, Cossu V, Ghiotto F, Ibatici A, Angelucci E, Neri A, Gentile M, Morabito F, Ferrarini M, Cutrona G, Fais F.   +16 more
europepmc   +1 more source

Clinical features of Marburg virus disease: a review of all reported patients since 1967. [PDF]

EClinicalMedicine
Pisapia R, Fusco FM, Scorzolini L, Fontana L, Nicastri E.   +4 more
europepmc   +1 more source

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351. [PDF]

Blood Adv
Palmieri R, Guolo F, Fianchi L, Ferrara F, Minetto P, Martelli MP, Riva C, Chiusolo P, Rondoni M, Capria S, Minotti C, Pilo F, Perrone S, Corbingi A, Grimaldi F, De Luca G, Fili C, Alati C, Mannelli F, Lessi F, Marchesi F, Brunetti L, Capelli D, Piccioni AL, Vetro C, Palumbo FE, Mazzone C, Sperotto A, Luzi G, Dargenio M, Mariani S, Cerrano M, Mulè A, Di Veroli A, Meddi E, Moretti F, Papayannidis C, Isidori A, Ferrari A, Galimberti S, Cilloni D, Breccia M, Lanza F, Gottardi M, Cairoli R, Candoni A, Pagano L, Todisco E, Lemoli RM, Venditti A, Buccisano F.   +50 more
europepmc   +1 more source

A novel therapy for eliminating phrenic nerve stimulation: a long-term follow-up case report. [PDF]

Front Cardiovasc Med
Li J, Yi H, Han H, Yan H.
europepmc   +1 more source

DP100 | BUSULFAN PHARMACOKINETIC-GUIDED CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULTS PATIENTS: RESULTS FROM A SINGLE CENTER

Haematologica
Busulfan (BU) is an alkylating agent with a large pharmacokinetic (PK) variability.After IV administration, an optimal BU therapeuticwindow, measured as Area Under Curve(AUC) between 16.000 and 24.000 μM x min hasbeenidentified.PK-guided BUdosingwas ...
R. Bono, G. Sapienza, C. Rotolo, S. Tringali, C. Spoto, A. Cucina, S. Indelicato, L. Castagna.   +7 more
doaj  

Endoscope-assisted supraorbital eyebrow approach for the treatment of ethmoidal dural arteriovenous fistula. [PDF]

Neurosurg Focus Video
D'Andrea M, Costanzo R, Ricci V, Fuschillo D, Visani J, Tosatto L.   +5 more
europepmc   +1 more source

Pure ankle dislocation in a 23-year-old man without fractures: a case report and a review of the literature. [PDF]

Trauma Case Rep
Lanari E, Ratto F, Vaggi S, Stella M, Formica M.   +4 more
europepmc   +1 more source

Time-dependent effects in consecutive cycles of prone positioning for acute respiratory failure: insights from the PROVENT-C19 Registry. [PDF]

J Anesth Analg Crit Care
Sella N, Boscolo A, Cortegiani A, Bellani G, Foti G, De Rosa S, Pitino A, Tripepi GL, Cattin L, De Cassai A, Elhadi M, Fullin G, Garofalo E, Gottin L, Grassetto A, Maggiore SM, Momesso E, Peta M, Pettenuzzo T, Poole D, Rona R, Zanoletti A, Rezoagli E, Navalesi P, SIAARTI Study Group.   +24 more
europepmc   +1 more source